<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A0F5FE7C-8820-488E-9121-EEA8CF4C6CF3"><gtr:id>A0F5FE7C-8820-488E-9121-EEA8CF4C6CF3</gtr:id><gtr:name>NIHR Oxford Biomedical Research Centre</gtr:name><gtr:address><gtr:line1>Botnar Research Centre</gtr:line1><gtr:line2>Nuffield Orthopaedic centre</gtr:line2><gtr:line3>Windmill Rd</gtr:line3><gtr:postCode>OX3 7LD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B82FA140-221B-4EA7-8FCF-F48ED0547504"><gtr:id>B82FA140-221B-4EA7-8FCF-F48ED0547504</gtr:id><gtr:name>School of Medicine Dundee</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3F0C5B38-6D5A-4C4B-81EC-BD11EF522AA4"><gtr:id>3F0C5B38-6D5A-4C4B-81EC-BD11EF522AA4</gtr:id><gtr:name>Department of Cardiovascular Medicine</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Psychiatry</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A0F5FE7C-8820-488E-9121-EEA8CF4C6CF3"><gtr:id>A0F5FE7C-8820-488E-9121-EEA8CF4C6CF3</gtr:id><gtr:name>NIHR Oxford Biomedical Research Centre</gtr:name><gtr:address><gtr:line1>Botnar Research Centre</gtr:line1><gtr:line2>Nuffield Orthopaedic centre</gtr:line2><gtr:line3>Windmill Rd</gtr:line3><gtr:postCode>OX3 7LD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B82FA140-221B-4EA7-8FCF-F48ED0547504"><gtr:id>B82FA140-221B-4EA7-8FCF-F48ED0547504</gtr:id><gtr:name>School of Medicine Dundee</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3F0C5B38-6D5A-4C4B-81EC-BD11EF522AA4"><gtr:id>3F0C5B38-6D5A-4C4B-81EC-BD11EF522AA4</gtr:id><gtr:name>Department of Cardiovascular Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/382F3EEB-8130-4EB4-9046-EC4190AD6E07"><gtr:id>382F3EEB-8130-4EB4-9046-EC4190AD6E07</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Cowen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A4D656C8-C91B-4436-AEA6-477BADFB162C"><gtr:id>A4D656C8-C91B-4436-AEA6-477BADFB162C</gtr:id><gtr:firstName>Zola</gtr:firstName><gtr:surname>Mannie</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0900576"><gtr:id>85B945D2-735F-4176-8E6A-695E70E8847A</gtr:id><gtr:title>Use of biomarkers to detect pre-symptomatic medical co-morbidity in young people at familial risk of depression</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900576</gtr:grantReference><gtr:abstractText>Clinical depression often develops in young people and can then recur over a lifetime. Once established, depression puts people at increased risk of other medical conditions such as diabetes, heart disease and memory problems. In our study we wish to explore the idea that depression and these other medical conditions are linked by increased secretion of a stress hormone called cortisol. We believe that the increase in cortisol secretion happens for many years before the illnesses actually occur. Increased cortisol secretion could theoretically account for why people become depressed and then develop the related medical conditions. If this is the case it might be possible to devise new methods of treatment which would prevent the development of both depression and its medical complications by lowering cortisol before the illnesses have become apparent.
We have recently found that young people at increased risk of depression through having a family history of the illness secrete too much cortisol before they have any evidence of depression or any other medical illness. If our idea is correct then we would expect the same young people to have evidence of abnormalities suggesting they are at risk of the medical conditions linked to depression. For example, they may show decreased efficiency of handling glucose (vulnerability to diabetes), changes in the elasticity of blood vessels (vulnerability to blood vessel disease) and smaller volume of a brain structure called the hippocampus (vulnerability to memory problems). This is what we will test in the present study.</gtr:abstractText><gtr:technicalSummary>Recurrent depression is a common condition with high morbidity often beginning in young adulthood and extending over the lifespan. Established depression is associated with several co-morbid general medical conditions, particularly obesity, diabetes, cardiovascular disease and cognitive decline. Pathophysiologically both depression and many of its medical co-morbidities share a liability to increased activity of the hypothalamo-pituitary-adrenal (HPA) axis. Our group has recently shown that increased waking salivary cortisol secretion has trait characteristics in people vulnerable to depression and indeed young people at increased familial risk of the illness hypersecrete cortisol despite never having experienced significant depressive symptomatology. The aim of the current proposal is to test the hypothesis that young people at increased familial risk of depression will also demonstrate abnormal markers of the associated medical conditions, specifically decreases in insulin sensitivity, endothelial function, declarative memory and hippocampal volume. Positive findings from this study could lead to a reconceptualisation of depression and its co-morbidities as responses within individuals to many years of asymptomatic but persistently increased cortisol secretion. This could lead to early intervention strategies targeting the activity of the HPA axis which could help prevent the eventual development of several highly burdensome clinical disorders</gtr:technicalSummary><gtr:fund><gtr:end>2012-12-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>449443</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>NIHR Oxford Biomedical Research Centre</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Medicine</gtr:department><gtr:description>Oxford Biomedical Research Centre</gtr:description><gtr:id>8CD34517-1582-4A20-8C1B-7159AE28678F</gtr:id><gtr:impact>papers submitted fro publication</gtr:impact><gtr:partnerContribution>provision of patients and immunological expertise</gtr:partnerContribution><gtr:piContribution>Study of the effect of interferon alpha on brain neurochemistry using MRS</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Medicine Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Cardiovascular and Diabetes Medicine</gtr:department><gtr:description>Aldosterone in metabolic complications of depression</gtr:description><gtr:id>3926CFD2-4CE2-4386-BF6B-815426D30EEE</gtr:id><gtr:impact>Grant application to MRC EMM csheme</gtr:impact><gtr:partnerContribution>World leading expertise in aldosterone and medicine. Measurement of aldosterone</gtr:partnerContribution><gtr:piContribution>Identification of raised aldosterone levels in young people at familial risk of depression</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department of Cardiovascular Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cardiovascular Clinical Research Facility (CCRF)</gtr:department><gtr:description>Oxford Cardiovascular Clinical Research Facility</gtr:description><gtr:id>1681498E-68FA-4E34-A3BC-BC81D6D3FB94</gtr:id><gtr:impact>Analysis of results in progress</gtr:impact><gtr:partnerContribution>Expertise in design of cardiovascular studies and their interpretation in young at-risk individuals</gtr:partnerContribution><gtr:piContribution>Collaboration to study cardiovascular risk factors in young people at increased risk of depression</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Oxford Neuroscience Festival</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>96171BD6-6EDF-4D9F-8FF9-891E33437912</gtr:id><gtr:impact>Keynote talk at Oxford Neuroscience Festival attended by several hundred undergraduates and graduates.

Approaches by medical students to carry out electives in our laboratory.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4B4453CE-93C9-41B7-AB14-49F00F8EADEA"><gtr:id>4B4453CE-93C9-41B7-AB14-49F00F8EADEA</gtr:id><gtr:title>Structural and functional imaging of the hippocampus in young people at familial risk of depression.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/883e93881f45f4205fb363e9972ff32e"><gtr:id>883e93881f45f4205fb363e9972ff32e</gtr:id><gtr:otherNames>Mannie ZN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AC060EE7-4056-4EB1-A5EC-FAC9862D05CF"><gtr:id>AC060EE7-4056-4EB1-A5EC-FAC9862D05CF</gtr:id><gtr:title>Imaging vulnerability for depression.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/66e098825713ff2a824ed36b33d241e9"><gtr:id>66e098825713ff2a824ed36b33d241e9</gtr:id><gtr:otherNames>Norbury R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/46EE797C-F795-4712-AB3F-00A556676FA7"><gtr:id>46EE797C-F795-4712-AB3F-00A556676FA7</gtr:id><gtr:title>Decision making in young people at familial risk of depression.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/883e93881f45f4205fb363e9972ff32e"><gtr:id>883e93881f45f4205fb363e9972ff32e</gtr:id><gtr:otherNames>Mannie ZN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B25E298C-1AF6-420A-8521-C718D72EF8D7"><gtr:id>B25E298C-1AF6-420A-8521-C718D72EF8D7</gtr:id><gtr:title>Cardiovascular and metabolic risk profile in young people at familial risk of depression.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/883e93881f45f4205fb363e9972ff32e"><gtr:id>883e93881f45f4205fb363e9972ff32e</gtr:id><gtr:otherNames>Mannie ZN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900576</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>